Mutual of America Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.2M | Sell |
|
|||||
|
2025
Q2 | $6.24M | Sell |
|
|||||
|
2025
Q1 | $7.75M | Sell |
|
|||||
|
2024
Q4 | $9.32M | Sell |
|
|||||
|
2024
Q3 | $14.2M | Sell |
|
|||||
|
2024
Q2 | $14.7M | Buy |
|
|||||
|
2024
Q1 | $13.4M | Sell |
|
|||||
|
2023
Q4 | $12.6M | Sell |
|
|||||
|
2023
Q3 | $12.3M | Sell |
|
|||||
|
2023
Q2 | $11.1M | Buy |
|
|||||
|
2023
Q1 | $12.6M | Buy |
|
|||||
|
2022
Q4 | $11M | Buy |
|
|||||
|
2022
Q3 | $10.2M | Buy |
|
|||||
|
2022
Q2 | $8.7M | Buy |
|
|||||
|
2022
Q1 | $9.94M | Sell |
|
|||||
|
2021
Q4 | $9.77M | Buy |
|
|||||
|
2021
Q3 | $9.32M | Buy |
|
|||||
|
2021
Q2 | $8.53M | Buy |
|
|||||
|
2021
Q1 | $6.88M | Buy |
|
|||||
|
2020
Q4 | $6.39M | Sell |
|
|||||
|
2020
Q3 | $7.65M | Buy |
|
|||||
|
2020
Q2 | $8.45M | Buy |
|
|||||
|
2020
Q1 | $5.31M | Buy |
|
|||||
|
2019
Q4 | $4.03M | Sell |
|
|||||
|
2019
Q3 | $2.99M | Buy |
|
|||||
|
2019
Q2 | $3.29M | Buy |
|
|||||
|
2019
Q1 | $4.3M | Buy |
|
|||||
|
2018
Q4 | $3.84M | Buy |
|
|||||
|
2018
Q3 | $4.02M | Sell |
|
|||||
|
2018
Q2 | $3.44M | Buy |
|
|||||
|
2018
Q1 | $3.4M | Buy |
|
|||||
|
2017
Q4 | $3.64M | Buy |
|
|||||
|
2017
Q3 | $4.26M | Buy |
|
|||||
|
2017
Q2 | $4.55M | Buy |
|
|||||
|
2017
Q1 | $3.53M | Buy |
|
|||||
|
2016
Q4 | $3.33M | Buy |
|
|||||
|
2016
Q3 | $3.6M | Sell |
|
|||||
|
2016
Q2 | $3.17M | Buy |
|
|||||
|
2016
Q1 | $3.21M | Buy |
|
|||||
|
2015
Q4 | $4.7M | Buy |
|
|||||
|
2015
Q3 | $3.98M | Buy |
|
|||||
|
2015
Q2 | $4.22M | Buy |
|
|||||
|
2015
Q1 | $3.72M | Buy |
|
|||||
|
2014
Q4 | $3.29M | Buy |
|
|||||
|
2014
Q3 | $2.86M | Sell |
|
|||||
|
2014
Q2 | $2.37M | Sell |
|
|||||
|
2014
Q1 | $2.66M | Buy |
|
|||||
|
2013
Q4 | $2.26M | Buy |
|
|||||
|
2013
Q3 | $2.51M | Sell |
|
|||||
|
2013
Q2 | $1.81M | Buy |
|